SCHNEYER MARK C. (Chief Financial Officer) sold 22.9% of their position (20.14K shares) of ACADIA PHARMACEUTICALS INC on the open market
Open‑market sale worth $587.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+5.85K
Price / share
$17.84
Trade value
$104.35K
% of position
Common Stock
Shares
−5.85K
Price / share
$29.00
Trade value
$169.64K
% of position
Common Stock
Shares
+14.29K
Price / share
$17.84
Trade value
$254.97K
% of position
Common Stock
Shares
−5K
Price / share
$29.00
Trade value
$145K
% of position
Common Stock
Shares
−9.29K
Price / share
$29.34
Trade value
$272.60K
% of position
Net shares
+0.00
Net value
-$227.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/5/2026 | M · Option Exercise | +5.85K | $17.84 | $104.35K | 8.6% | 67.83K | 73.68K |
| Common Stock Direct | 8/5/2026 | S · Sale | −5.85K | $29.00 | $169.64K | 7.9% | 73.68K | 67.83K |
| Common Stock Direct | 8/6/2026 | M · Option Exercise | +14.29K | $17.84 | $254.97K | 21.1% | 67.83K | 82.12K |
| Common Stock Direct | 8/6/2026 | S · Sale | −5K | $29.00 | $145K | 6.1% | 82.12K | 77.12K |
| Common Stock Direct | 8/6/2026 | S · Sale | −9.29K | $29.34 | $272.60K | 12.0% | 77.12K | 67.83K |
| Total | +0.00 | -$227.93K | ||||||
Stock Option (Right to Buy)
Common Stock
5.85K shares
Shares
−5.85K
Strike price
17.84
Held after
74.72K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
14.29K shares
Shares
−14.29K
Strike price
17.84
Held after
60.42K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5.85K shares | 8/5/2026 | M · Option Exercise | −5.85K | 17.84 | — | 74.72K |
| Stock Option (Right to Buy) Direct | Common Stock14.29K shares | 8/6/2026 | M · Option Exercise | −14.29K | 17.84 | — | 60.42K |